Companies selling risky stem cell products receive FDA warning!!!

Companies in the United States that had been selling products derived from umbilical cord blood — usually involving stem cells — without approval from the Food and Drug Administration (FDA) have now received urgent warnings from the agency.

Umbilical cord blood is a great source of stem cells. These are unspecialized cells that have the ability to transform into virtually any type of cell.

For this reason, stem cell therapy is becoming increasingly sought after for the treatment of all sorts of conditions and physical injuries. This is despite the fact that research into this form of therapy is still in its early stages in many ways.

Recently, however, the FDA identified several companies that were selling umbilical cord-derived products without their approval.

[Source: Medical News Today]